BRIDGEWATER, N.J., Feb. 10, 2022 /PRNewswire/ -- Insmed
Incorporated (Nasdaq: INSM), a global biopharmaceutical company on
a mission to transform the lives of patients with serious and rare
diseases, today announced that management will present at the SVB
Leerink Virtual 11th Annual Global Healthcare Conference
on February 18, 2022 at 10:00 a.m. ET.
The fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. The webcast will be archived for a period of 30
days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed's first commercial
product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung
disease. The Company is also progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-svb-leerink-virtual-11th-annual-global-healthcare-conference-301479147.html
SOURCE Insmed Incorporated